Sangamo BioSciences (SGMO)
Create an Alert
7.92
-0.26 -3.18%
NASDAQ
Jun 19, 5:00PM
BATS Real time
Currency in USD
Sangamo BioSciences Cash from Investing Quarterly:
-3.731M for March 31, 2013Sangamo BioSciences Historical Cash from Investing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -3.731M |
| Dec. 31, 2012 | 7.097M |
| Sept. 30, 2012 | -0.13M |
| June 30, 2012 | -0.397M |
| March 31, 2012 | 4.749M |
| Dec. 31, 2011 | -5.115M |
| Sept. 30, 2011 | 19.64M |
| June 30, 2011 | -41.73M |
| March 31, 2011 | 7.206M |
| Dec. 31, 2010 | 3.788M |
| Sept. 30, 2010 | 2.192M |
| June 30, 2010 | 7.705M |
| March 31, 2010 | -1.311M |
| Dec. 31, 2009 | -30.61M |
| Sept. 30, 2009 | 3.682M |
| June 30, 2009 | 5.383M |
| March 31, 2009 | 2.371M |
| Dec. 31, 2008 | 5.366M |
| Sept. 30, 2008 | 4.905M |
| June 30, 2008 | 7.938M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Cash From Investing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More
SGMO Cash from Investing Quarterly Benchmarks
| Companies | |
|---|---|
| Achillion Pharmaceuticals | -99.19M |
| Infinity Pharmaceuticals | -51.78M |
| Immunogen | -0.307M |
SGMO Cash from Investing Quarterly Rankings
| Overall |
71st percentile 4791 of 16782 |
| Sector |
54th percentile 635 of 1410 in Healthcare |
| Industry |
42nd percentile 261 of 454 in Biotechnology |
SGMO Cash from Investing Quarterly Range, Past 5 Years
| Minimum | -41.73M | Jun 2011 |
| Maximum | 19.64M | Sep 2011 |
| Average | -0.0503M |
